TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
PE Bioprocess Consulting AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
283
|
228
|
406 |
Financial expenses |
0
|
15
|
0 |
Earnings before taxes |
12
|
222
|
180 |
EBITDA |
4
|
-49
|
114 |
Total assets |
595
|
694
|
633 |
Current assets |
356
|
455
|
351 |
Current liabilities |
57
|
68
|
129 |
Equity capital |
538
|
626
|
504 |
- share capital |
100
![]() |
100
![]() |
100 |
Employees (average) |
1
![]() |
1
![]() |
1 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
90.4%
|
90.2%
|
79.6% |
Turnover per employee |
283
|
228
|
406 |
Profit as a percentage of turnover |
4.2%
|
97.4%
|
44.3% |
Return on assets (ROA) |
2.0%
|
34.1%
|
28.4% |
Current ratio |
624.6%
|
669.1%
|
272.1% |
Return on equity (ROE) |
2.2%
|
35.5%
|
35.7% |
Change turnover |
55
|
-178
|
329 |
Change turnover % |
24%
|
-44%
|
427% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.